INSPIRE 8F PH.I.S.I.O.Recalls & reported problems
Sorin Group Italia Srl · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 16
- Deaths reported
- 1
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 16 adverse event reports that list this exact device (DI 08033178112383), received between Aug 5, 2016 and Jul 31, 2026 — classified as 1 death, 2 injuries, 12 malfunctions.
The most frequently reported specific device problem is “Increase in Pressure” (7 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Increase in Pressure7
- Fluid/Blood Leak6
- Device Contaminated During Manufacture or Shipping2
- Pressure Problem2
- Unexpected Therapeutic Results1
Patient problems
- No Clinical Signs, Symptoms or Conditions5
- No Consequences Or Impact To Patient3
- No Patient Involvement2
- Brain Injury1
- Death1
- Hematuria1
- Hypoxia1
- Inflammation1
Recent adverse event reports
The 16 most recent of 16 reports, in the reporter's own words as published by the FDA.
InjuryJul 31, 2026Fluid/Blood Leak
Sorin Group Italia received a report of a leakage from an Inspire 8F oxygenator. The event occurred after 1 hour and 30 minutes of blood circulation. Reportedly, during procedure patient experienced elevated lactate levels and hypoxemia. Consequently, blood transfusion was conducted, which has been considered an additional medical intervention to preclude a serious injury.
Patient problems: Hypoxia
MAUDE report 50099526 ↗InjuryDec 24, 2025Fluid/Blood Leak; Fluid/Blood Leak
SEE INITIAL REPORT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23886901 ↗MalfunctionJan 15, 2025Increase in Pressure; Increase in Pressure
SORIN GROUP ITALIA HAS RECEIVED A REPORT OF INCREASED TRANS-MEMBRANE PRESSURE ACROSS INSPIRE OXYGENATOR DURING A PROCEDURE. MEDICAL TEAM ELECTED TO CHANGE-OUT THE OXYGENATOR. PATIENT CONSEQUENCES WERE NOT DISCLOSED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21156548 ↗MalfunctionDec 19, 2024Increase in Pressure; Increase in Pressure
MalfunctionAug 2, 2023Increase in Pressure; Unexpected Therapeutic Results; Increase in Pressure; Unexpected Therapeutic Results
SORIN GROUP ITALIA RECEIVED A REPORT THAT HIGH TRANSMEMBRANE PRESSURE OCCURRED DURING A PROCEDURE. MEDICAL TEAM ELECTED TO ADMINISTER MAG 2GM AND ALBUMIN 12.5GM. SURGERY WAS COMPLETED WITHOUT ANY NEED FOR UNIT CHANGE-OUT. THERE IS NO REPORT OF ANY PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 17442777 ↗MalfunctionNov 17, 2022Fluid/Blood Leak; Fluid/Blood Leak
SEE INITIAL REPORT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15812842 ↗MalfunctionMay 6, 2022Fluid/Blood Leak; Increase in Pressure; Fluid/Blood Leak; Increase in Pressure
SORIN GROUP ITALIA HAS RECEIVED A REPORT THAT, DURING A PROCEDURE, THE TRANSMEMBRANE PRESSURE ACROSS AN INSPIRE 8F OXYGENATOR INCREASED CAUSING LEAKAGE. MEDICAL TEAM ELECTED TO CHANGE-OUT THE OXYGENATOR. THE PROCEDURE WAS PROLONGED. PATIENT IMPACT IS BLOOD LOSS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14306936 ↗DeathAug 11, 2020Increase in Pressure; Increase in Pressure
SORIN GROUP (B)(4) HAS RECEIVED A REPORT THAT, 30 MINUTES AFTER THE BEGIN OF THE PROCEDURE, THE VALUES OF THE TRANSMEMBRANE PRESSURE OF THE INSPIRE OXYGENATOR WERE HIGH. THE MEDICAL TEAM ELECTED TO CHANGE OUT THE OXYGENATOR. AFTER THE CHANGE OUT, THE VALUES OF THE TRANSMEMBRANE PRESSURE BACK TO NORMAL. LIVANOVA HAS BEEN INFORMED THE PATIENT HAS DIED ON THE SAME DATE (B)(6) 2020). THE MEDICAL TEAM DOES NOT BELIEVE THERE IS ANY CORRELATION BETWEEN THE EVENT AND PATIENT DEMISE.
Patient problems: Death
MAUDE report 10391318 ↗MalfunctionDec 23, 2019Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping
MalfunctionDec 23, 2019Device Contaminated During Manufacture or Shipping; Device Contaminated During Manufacture or Shipping
SORIN GROUP (B)(4) HAS RECEIVED A REPORT THAT, DURING SET-UP, A FOREIGN MATERIAL WAS SEEN BY THE CARDIOPLEGIA ARTERIAL OUTLET OF THE INSPIRE 8F. THE DEVICE WAS CHANGED-OUT. THE ISSUE OCCURRED PRIOR TO PATIENT INVOLVEMENT.
Patient problems: No Patient Involvement
MAUDE report 9510692 ↗MalfunctionJul 18, 2019Fluid/Blood Leak; Fluid/Blood Leak
LIVANOVA RECEIVED A REPORT THAT, DURING A CARDIOPULMONARY BYPASS, LEAKAGE FROM THE TEMPERATURE PROBE HOLDER WAS OBSERVED. THE EVENT OCCURRED AT THE END OF THE PROCEDURE, WHEN THE PERFUSIONIST REMOVED THE TEMPERATURE PROBE FROM THE HOUSING, IT WAS NOT NECESSARY TO REPLACE THE OXYGENATING SYSTEM. THERE WAS NO LEAKAGE DURING SURGERY. THE MEDICAL TEAM ELECTED TO ADMINISTER BROAD-SPECTRUM ANTIBIOTIC TO THE PATIENT. THERE WAS NO REPORT OF PATIENT INJURY.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 8802337 ↗MalfunctionMar 15, 2019Pressure Problem; Pressure Problem
MalfunctionFeb 13, 2019Pressure Problem; Pressure Problem
SORIN GROUP (B)(6) HAS RECEIVED A REPORT THAT, 10 MINUTES AFTER THE BEGINNING OF A PROCEDURE, THE DELTA TRANS-MEMBRANE PRESSURE OF THE INSPIRE 8F OXYGENATOR ROSE TO 300 MMHG. THE MEDICAL TEAM ELECTED TO CHANGE-OUT RESERVOIR, OXYGENATOR AND EQUIPMENT. THE PROCEDURE WAS COMPLETED WITH NO ISSUE. THERE IS NO REPORT OF ANY PATIENT INJURY. ON (B)(6) 2019, SORIN GROUP (B)(6) HAS BEEN INFORMED THE CHANGE-OUT TOOK 5 MINUTES.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8335073 ↗MalfunctionJul 13, 2018Increase in Pressure; Increase in Pressure
SORIN GROUP (B)(4) RECEIVED A REPORT THAT THE TRANSMEMBRANE PRESSURE OF THE INSPIRE 8F DUAL HOLLOW FIBER OXYGENATOR INCREASED DURING A PROCEDURE. THE USER WAS ABLE TO DECREASE THE PRESSURE SLIGHTLY BY INCREASING THE BLOOD TEMPERATURE FROM 34°C TO 37°C. AFTER THE PROCEDURE, THE PATIENT REPORTEDLY EXPERIENCED HAEMATURIA AND STRONGER THAN NORMAL SYSTEMIC INFLAMMATORY RESPONSE SYNDROME. DURING FOLLOW-UP INFORMATION SORIN HAS BEEN INFORMED THAT THERE IS NO REPORT OF PATIENT INJURY.
Patient problems: Hematuria; Inflammation
MAUDE report 7684656 ↗MalfunctionApr 24, 2018Increase in Pressure; Increase in Pressure
SORIN GROUP (B)(4) RECEIVED A REPORT THAT THE PRE-MEMBRANE PRESSURE OF AN INSPIRE 8F HOLLOW FIBER OXYGENATOR AND THE TENSION OF THE TUBING BETWEEN THE PUMP OUTLET AND THE OXYGENATOR INLET INCREASED DURING A PROCEDURE. THE REPORT ALSO INDICATED THAT THE PUMP FLOW COULD NOT BE SET HIGHER THAN 2 LPM. THE MEDICAL TEAM ELECTED TO CHANGE OUT THE OXYGENATOR, WHICH TOOK ROUGHLY 200 SECONDS. THERE WAS NO REPORT OF PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7454954 ↗Aug 5, 2016Fluid/Blood Leak; Fluid/Blood Leak
SORIN GROUP (B)(4) RECEIVED A REPORT THAT, DURING EXTRACORPOREAL CIRCULATION, A BLOOD LEAK WAS DETECTED FROM THE TEMPERATURE PROBE OF THE INSPIRE 8F DUAL HOLLOW FIBER OXYGENATOR WITH INTEGRATED HARDSHELL VENOUS CARDIOTOMY RESERVOIR. THERE WAS NO REPORT OF PATIENT INJURY.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 5850213 ↗
Other OXYGENATOR, CARDIOPULMONARY BYPASS devices
- HLS Set BEQ-HLS 7050 USAMaquet Cardiopulmonary AG · Oxygenator, Cardiopulmonary Bypass3 recalls13 deaths90 reports
- Affinity Fusion® BB811Medtronic, Inc. · OXYGENATOR, CARDIOPULMONARY BYPASS2 recalls90 reports
- HLS Set BEQ-HLS 5050 USAMaquet Cardiopulmonary AG · Oxygenator, Cardiopulmonary Bypass3 recalls4 reports
- NA HLS Set Advanced 5.0, Small Adult, BIOLINE CoatingMaquet Cardiopulmonary AG · OXYGENATOR, CARDIOPULMONARY BYPASS3 recalls0 reports
- A.M.G. PMP Sterile A.M.G. Module PMP NO T.P. SterileEurosets Srl · Oxygenator, Cardiopulmonary Bypass2 deaths106 reports
- CAPIOX®FX CX*FX25RWTerumo Corporation · Oxygenator, Cardiopulmonary Bypass2 deaths102 reports
- CAPIOX®RX CX*RX25RWTerumo Corporation · Oxygenator, Cardiopulmonary Bypass1 death102 reports
- QUADROX-i HMO 50000-USA #SQUADROX-i Small Adult, no FilterMaquet Cardiopulmonary AG · OXYGENATOR, CARDIOPULMONARY BYPASS2 recalls0 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page